Ferring Acquires Innovative Biotechnology Company and Microbiome Pionee
Rebiotix’s RBX2660 is a non-antibiotic treatment in Phase 3 development for...
2018-04-10
文传商讯
Ferring enters into worldwide OmniAb platform license agreement with Li
Ferring Pharmaceuticals will use Ligand’s OmniAb® platform to disc...
2018-01-23
文传商讯
Ferring Partners with Intralytix to Develop Bacteriophage Treatments fo
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals is partner...
2017-01-11
文传商讯
